Company Data

Eledon Pharmaceuticals

Fundamental Analysis:

Eledon Pharmaceuticals

Eledon Pharmaceuticals
Fundamental Analysis:
Current Price
$2.82 -6.93%
Market Cap
Price Target
Refer to Report
52wk Range
$1.07 - $3.349
Advanced Market Data


Eledon Pharmaceuticals is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target with broad therapeutic potential. Eledon is headquartered in Irvine, California. For more information, please visit the company’s website at

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy